allergan inc (AG4:Berlin)
Executive Profile*
Douglas S. Ingram J.D., Esq.Executive Vice President and President of Europe, Africa & Middle East, Allergan Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 5 different industries. |
| 49 | $7,261,324 As of Fiscal Year 2012 |
Background*
Mr. Douglas S. Ingram, JD, Esq. has been an Executive Vice President of Allergan Inc. since August 1, 2010 and has been its President, Europe, Africa, Middle East since August 1, 2010. Mr. Ingram served as the Chief Administrative Officer and Chief Ethics Officer of Allergan Inc., since October 2006 and since July 2001 respectively and also its Executive Vice President, General Counsel and Secretary since October 2003. He served as the Corporate Vice President of Allergan ...
Corporate Headquarters*2525 Dupont DriveIrvine, California 92612 United States Phone: 714-246-4500 Fax: 714-246-6987 Board Members Memberships*Former Trustee 2005-2007 Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 2005-2011 Lead Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Education*JD 1988 The University of Arizona BA 1985 Arizona State University-Tempe
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| AG4:GR | €75.70 EUR | +0.74 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Leonard S. Schleifer M.D., Ph.D. | Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee Regeneron Pharmaceuticals, Inc. | $3.3M |
| Paul M. Bisaro | Chief Executive Officer, President and Director Actavis, Inc. | $2.4M |
| J. Michael Pearson | Chairman and Chief Executive Officer Valeant Pharmaceuticals International, Inc. | $1.7M |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- |
| Yoshihiko Hatanaka | Chief Executive Officer, President and Representative Director Astellas Pharma, Inc. | -- | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
